Literature DB >> 31927332

Cross-presentation of exogenous antigens on MHC I molecules.

Jeff D Colbert1, Freidrich M Cruz1, Kenneth L Rock2.   

Abstract

In order to get recognized by CD8 T cells, most cells present peptides from endogenously expressed self or foreign proteins on MHC class I molecules. However, specialized antigen-presenting cells, such as DCs and macrophages, can present exogenous antigen on MHC-I in a process called cross-presentation. This pathway plays key roles in antimicrobial and antitumor immunity, and also immune tolerance. Recent advances have broadened our understanding of the underlying mechanisms of cross-presentation. Here, we review some of these recent advances, including the distinct pathways that result in the cross-priming of CD8 T cells and the source of the class I molecules presenting exogenous peptides.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31927332      PMCID: PMC7343603          DOI: 10.1016/j.coi.2019.12.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  99 in total

1.  A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen.

Authors:  Nawel Merzougui; Roland Kratzer; Loredana Saveanu; Peter van Endert
Journal:  EMBO Rep       Date:  2011-12-01       Impact factor: 8.807

2.  Presentation of exogenous antigen with class I major histocompatibility complex molecules.

Authors:  K L Rock; S Gamble; L Rothstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

3.  The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation.

Authors:  Elke Firat; Loredana Saveanu; Peter Aichele; Peter Staeheli; Jisen Huai; Simone Gaedicke; Ahmed Nil; Gilles Besin; Benoît Kanzler; Peter van Endert; Gabriele Niedermann
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

4.  The Content of CpG-DNA in Antigen-CpG Conjugate Vaccines Determines Their Cross-Presentation Activity.

Authors:  Ryan M Clauson; Brendan Berg; Beata Chertok
Journal:  Bioconjug Chem       Date:  2019-02-15       Impact factor: 4.774

5.  C-Type lectin receptor(s)-targeted nanoliposomes: an intelligent approach for effective cancer immunotherapy.

Authors:  Rajeev Sharma; Nishi Mody; Varun Kushwah; Sanyog Jain; S P Vyas
Journal:  Nanomedicine (Lond)       Date:  2017-07-31       Impact factor: 5.307

6.  TAP-Dependent and -Independent Peptide Import into Dendritic Cell Phagosomes.

Authors:  Myriam Lawand; Anastasia Abramova; Valérie Manceau; Sebastian Springer; Peter van Endert
Journal:  J Immunol       Date:  2016-09-23       Impact factor: 5.422

7.  IRAP identifies an endosomal compartment required for MHC class I cross-presentation.

Authors:  Loredana Saveanu; Oliver Carroll; Mirjana Weimershaus; Pierre Guermonprez; Elke Firat; Vivian Lindo; Fiona Greer; Jean Davoust; Roland Kratzer; Susanna R Keller; Gabriele Niedermann; Peter van Endert
Journal:  Science       Date:  2009-06-04       Impact factor: 47.728

8.  TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation.

Authors:  Priyanka Nair-Gupta; Alessia Baccarini; Navpreet Tung; Fabian Seyffer; Oliver Florey; Yunjie Huang; Meenakshi Banerjee; Michael Overholtzer; Paul A Roche; Robert Tampé; Brian D Brown; Derk Amsen; Sidney W Whiteheart; J Magarian Blander
Journal:  Cell       Date:  2014-07-31       Impact factor: 41.582

9.  Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells.

Authors:  C Kurts; H Kosaka; F R Carbone; J F Miller; W R Heath
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

10.  Lipid peroxidation causes endosomal antigen release for cross-presentation.

Authors:  Ilse Dingjan; Daniëlle Rj Verboogen; Laurent M Paardekooper; Natalia H Revelo; Simone P Sittig; Linda J Visser; Gabriele Fischer von Mollard; Stefanie Sv Henriet; Carl G Figdor; Martin Ter Beest; Geert van den Bogaart
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

View more
  16 in total

Review 1.  A guide to antigen processing and presentation.

Authors:  Novalia Pishesha; Thibault J Harmand; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2022-04-13       Impact factor: 53.106

2.  Tetraspanin-5-mediated MHC class I clustering is required for optimal CD8 T cell activation.

Authors:  Jeff D Colbert; Freidrich M Cruz; Christina E Baer; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

Review 3.  Cross-Presenting XCR1+ Dendritic Cells as Targets for Cancer Immunotherapy.

Authors:  Katherine M Audsley; Alison M McDonnell; Jason Waithman
Journal:  Cells       Date:  2020-02-28       Impact factor: 6.600

Review 4.  Targeting ubiquitin signaling for cancer immunotherapy.

Authors:  Xiaofei Zhou; Shao-Cong Sun
Journal:  Signal Transduct Target Ther       Date:  2021-01-13

Review 5.  Dendritic Cells: Neglected Modulators of Peripheral Immune Responses and Neuroinflammation in Mood Disorders?

Authors:  Rafael Leite Dantas; Jana Freff; Oliver Ambrée; Eva C Beins; Andreas J Forstner; Udo Dannlowski; Bernhard T Baune; Stefanie Scheu; Judith Alferink
Journal:  Cells       Date:  2021-04-19       Impact factor: 6.600

Review 6.  The Impact of the Ca2+-Independent Phospholipase A2β (iPLA2β) on Immune Cells.

Authors:  Tayleur D White; Abdulaziz Almutairi; Ying Gai Tusing; Xiaoyong Lei; Sasanka Ramanadham
Journal:  Biomolecules       Date:  2021-04-15

Review 7.  Recent Progress in Dendritic Cell-Based Cancer Immunotherapy.

Authors:  Kazuhiko Matsuo; Osamu Yoshie; Kosuke Kitahata; Momo Kamei; Yuta Hara; Takashi Nakayama
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

Review 8.  Shaping of T Cell Functions by Trogocytosis.

Authors:  Masafumi Nakayama; Arisa Hori; Saori Toyoura; Shin-Ichiro Yamaguchi
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

Review 9.  Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines.

Authors:  Maarten K Nijen Twilhaar; Lucas Czentner; Cornelus F van Nostrum; Gert Storm; Joke M M den Haan
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

Review 10.  The Origin and Immune Recognition of Tumor-Specific Antigens.

Authors:  Anca Apavaloaei; Marie-Pierre Hardy; Pierre Thibault; Claude Perreault
Journal:  Cancers (Basel)       Date:  2020-09-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.